The Glaucoma Research Foundation (GRF) announced that Dennis Singleton is the 2009 recipient of its Visionary Award. Mr. Singleton, a long-time member of the GRF board, is being honored for his dedication to the cause of glaucoma research and education.
His vision for the future helped guide the development of the Foundation’s strategic plan and he led a successful capital campaign conducted by GRF to fund the plan.
Mr. Singleton has served on the Board of Directors for the Glaucoma Research Foundation since 1998, and served as Board Chairman from July 2003 through June 2006. Under his leadership, the Foundation realized its greatest growth in contributed income and the 3-year Catalyst For a Cure Campaign he led exceeded its revenue goal of $7.5 million raising a total of $8.6 million to support glaucoma research.
Singleton was presented the award by last year’s Visionary and founder of the Glaucoma Research Foundation, John Hetherington, MD, Clinical Professor of Ophthalmology at the University of California San Francisco.
The Visionary Award also recognizes Mr. Singleton’s philanthropic generosity as one of the Glaucoma Research Foundation’s most generous contributors. As Chair of the Strategic Planning Committee, he led the creation of the plan in 2007, and he continues to guide the Foundation’s course to achieve its strategic objectives.
“Dennis took office as Board Chair shortly after I joined GRF in 2003,” said Thomas M. Brunner, GRF President and CEO, “and his leadership provided a wonderful opportunity to learn from him and work together towards a greater vision for the Glaucoma Research Foundation.”
Mr. Singleton was Vice Chairman of Spieker Properties, Inc., a real estate investment trust, from 1998 until 2003, and served as Executive VP and CIO of that company from 1993 to 1997. He was a founding partner in 1987 and began his career in real estate with the Trammell Crow Company in 1972. Mr. Singleton has overseen the development and acquisition of more than 28,000,000 square feet of commercial properties representing an investment of over $3 billion. Mr. Singleton received a Bachelor of Science from Lehigh University and a Masters in Business Administration from Harvard Graduate School of Business Administration.
Source
Glaucoma Research Foundation